checkAd

     109  0 Kommentare Veracyte Announces Data for Pulmonology Portfolio to be Presented at American Thoracic Society 2021 International Conference - Seite 4

    Veracyte, Afirma, Percepta, Envisia, Prosigna, "Know by Design" and the Veracyte, Afirma, Percepta, Envisia and Prosigna logos are registered trademarks of Veracyte in the U.S. and selected countries.

    nCounter is the registered trademark of NanoString Technologies, Inc. in the United States and other countries and used by Veracyte under license.


    Business Wire (engl.)
    0 Follower
    Autor folgen
    Seite 4 von 4

    Veracyte Announces Data for Pulmonology Portfolio to be Presented at American Thoracic Society 2021 International Conference - Seite 4 Veracyte, Inc. (Nasdaq: VCYT) announced today that new data demonstrating the clinical capability of the Percepta Genomic Atlas for informing lung cancer treatment decisions, as well as the technical feasibility of enabling the company’s Envisia …